Anticancer Properties of Solamargine: A Systematic Review

Cancers are usually treated by anticancer agents that are toxic for both normal and cancer cells, so these drugs have major side effects and they are not suitable and enough effective for cancer prevention. Solamargine, a steroidal alkaloid glycoside found in Solanum species such as Solanum nigrum, displayed several therapeutic activities. We aim to review the use of solamargine in experimental cancer studies. Articles published in biology journals between 1975 and 2017 were retrieved from PubMed, Scopus, and Web of Science using relevant keywords. The scientific papers mainly focusing on solamargine with therapeutic efficacies against cancers were identified and tabulated. In addition, the reliability of experimental findings was determined under “Risk of Bias” criteria. The author manually reviewed 33 articles; 27 articles were found concerning the anti‐cancer potential in cancer cells. Solamargine has been found to possess anticancer activities via its effect on a variety of biological pathways including cell survival pathways, tumor suppressor pathways, caspase activation pathway, mitochondrial pathways, death receptor pathways, protein kinase pathways, and signal pathways, which promote invasion/migration and multi drug resistance. Solamargine can be an anticancer agent candidate when complementary scientific evidences become available. Copyright © 2017 John Wiley & Sons, Ltd.

[1]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[2]  K. Kuo,et al.  Solamargine purified from Solanum incanum Chinese herb triggers gene expression of human TNFR I which may lead to cell apoptosis. , 1996, Biochemical and biophysical research communications.

[3]  Axel Benner,et al.  Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma. , 2003, Cancer research.

[4]  S. Ambudkar,et al.  Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1. , 2014, Biochemical pharmacology.

[5]  Haike Ghazarian,et al.  A glycobiology review: carbohydrates, lectins and implications in cancer therapeutics. , 2011, Acta histochemica.

[6]  Ivan Stamenkovic,et al.  Extracellular matrix remodelling: the role of matrix metalloproteinases , 2003, The Journal of pathology.

[7]  U. Brunk,et al.  The lysosomal-mitochondrial axis theory of postmitotic aging and cell death. , 2006, Chemico-biological interactions.

[8]  B. Aggarwal,et al.  Cancer is a Preventable Disease that Requires Major Lifestyle Changes , 2008, Pharmaceutical Research.

[9]  G. Majno,et al.  Apoptosis, oncosis, and necrosis. An overview of cell death. , 1995, The American journal of pathology.

[10]  R. Weinberg,et al.  A Perspective on Cancer Cell Metastasis , 2011, Science.

[11]  S. Elmore.  Apoptosis: A Review of Programmed Cell Death , 2007, Toxicologic pathology.

[12]  A. Usubillaga,et al.  Toxicological effects of α‐solamargine in experimental animals , 2003 .

[13]  B. Cookson,et al.  Apoptosis, Pyroptosis, and Necrosis: Mechanistic Description of Dead and Dying Eukaryotic Cells , 2005, Infection and Immunity.

[14]  A. Mahdi,et al.  Selective cell cycle arrest and induction of apoptosis in human prostate cancer cells by a polyphenol-rich extract of Solanum nigrum , 2011, International journal of molecular medicine.

[15]  D. Gutmann,et al.  Astrocyte-specific expression of CDK4 is not sufficient for tumor formation, but cooperates with p53 heterozygosity to provide a growth advantage for astrocytes in vivo , 2002, Oncogene.

[16]  Ying Wang,et al.  Solamargine triggers hepatoma cell death through apoptosis. , 2015, Oncology letters.

[17]  K. Stoeber,et al.  The cell cycle and cancer , 2012, The Journal of pathology.

[18]  L. Liu,et al.  Anticancer activity evaluation of the solanum glycoalkaloid solamargine. Triggering apoptosis in human hepatoma cells. , 2000, Biochemical pharmacology.

[19]  P. Mukherjee,et al.  MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes , 2013, Oncogenesis.

[20]  G. Gu,et al.  In Situ RBL Receptor Visualization and Its Mediated Anticancer Activity for Solasodine Rhamnosides , 2011, Chembiochem : a European journal of chemical biology.

[21]  W. K. Roberts,et al.  Human MDR 1 protein overexpression delays the apoptotic cascade in Chinese hamster ovary fibroblasts. , 1997, Biochemistry.

[22]  Mengtao Zhou,et al.  Antitumor Efficacy of α-Solanine against Pancreatic Cancer In Vitro and In Vivo , 2014, PloS one.

[23]  D. Tarin.  Cell and tissue interactions in carcinogenesis and metastasis and their clinical significance. , 2011, Seminars in cancer biology.

[24]  D. Tarin.  Comparisons of Metastases in Different Organs: Biological and Clinical Implications , 2008, Clinical Cancer Research.

[25]  Guido Kroemer,et al.  Cell death by necrosis: towards a molecular definition. , 2007, Trends in biochemical sciences.

[26]  Huiqing Yuan,et al.  A lysosomal-mitochondrial death pathway is induced by solamargine in human K562 leukemia cells. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[27]  A. E. Almeida,et al.  In vitro trypanocidal activity of solamargine and extracts from Solanum palinacanthum and Solanum lycocarpum of Brazilian cerrado. , 2013, Anais da Academia Brasileira de Ciencias.

[28]  I. K. Berezesky,et al.  The Pathways of Cell Death: Oncosis, Apoptosis, and Necrosis , 1997, Toxicologic pathology.

[29]  Rebecca L. Siegel Mph,et al.  Cancer statistics, 2016 , 2016 .

[30]  C. Devi,et al.  Antiulcerogenic and ulcer healing effects of Solanum nigrum (L.) on experimental ulcer models: possible mechanism for the inhibition of acid formation. , 2006, Journal of ethnopharmacology.

[31]  T. Wilt,et al.  Risk of Bias , 2012 .

[32]  Stephen Safe,et al.  Natural Products as Mechanism‐based Anticancer Agents: Sp Transcription Factors as Targets , 2016, Phytotherapy research : PTR.

[33]  P. F. Oliveira,et al.  Antiproliferative activity of Solanum lycocarpum alkaloidic extract and their constituents, solamargine and solasonine, in tumor cell lines , 2013, Journal of Natural Medicines.

[34]  K. Kuo,et al.  Action of solamargine on human lung cancer cells – enhancement of the susceptibility of cancer cells to TNFs , 2004, FEBS letters.

[35]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[36]  W. Wu,et al.  Solamargine induces apoptosis associated with p53 transcription-dependent and transcription-independent pathways in human osteosarcoma U2OS cells. , 2011, Life sciences.

[37]  J. Mei,et al.  Induction of actin disruption and downregulation of P-glycoprotein expression by solamargine in multidrug-resistant K562/A02 cells , 2011 .

[38]  L. Rosella,et al.  Risk of Bias in Systematic Reviews of Non-Randomized Studies of Adverse Cardiovascular Effects of Thiazolidinediones and Cyclooxygenase-2 Inhibitors: Application of a New Cochrane Risk of Bias Tool , 2016, PLoS medicine.

[39]  M. Jäättelä,et al.  Lysosomes as targets for cancer therapy. , 2005, Cancer research.

[40]  S. Jane,et al.  Mutational analysis of P-glycoprotein: suppression of caspase activation in the absence of ATP-dependent drug efflux , 2004, Cell Death and Differentiation.

[41]  D. Green,et al.  Mechanisms of p53-dependent apoptosis. , 2001, Biochemical Society transactions.

[42]  Qing Tang,et al.  Targeting EP4 downstream c‐Jun through ERK1/2‐mediated reduction of DNMT1 reveals novel mechanism of solamargine‐inhibited growth of lung cancer cells , 2016, Journal of cellular and molecular medicine.

[43]  Yingyu Cui,et al.  Effects of anthocyanins on the prevention and treatment of cancer , 2017, British journal of pharmacology.

[44]  F. Kiessling,et al.  Multidrug resistance: Physiological principles and nanomedical solutions. , 2013, Advanced drug delivery reviews.

[45]  Ming Xu,et al.  DNA fragmentation in apoptosis , 2000, Cell Research.

[46]  D. Kufe,et al.  MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia , 2016, Oncotarget.

[47]  Shao-Ru Chen,et al.  Herbal Medicine Offered as an Initiative Therapeutic Option for the Management of Hepatocellular Carcinoma , 2016, Phytotherapy research : PTR.

[48]  I. Urushizaki.  [Palliative therapy in cancer. 5. Side effects by anticancer drugs and their treatments]. , 1990, Gan to kagaku ryoho. Cancer & chemotherapy.

[49]  Li-Ching Chang,et al.  Action of solamargine on TNFs and cisplatin-resistant human lung cancer cells. , 2004, Biochemical and biophysical research communications.

[50]  C. Gialeli,et al.  Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting , 2011, The FEBS journal.

[51]  K. Kuo,et al.  Downregulation of HER2/neu receptor by solamargine enhances anticancer drug-mediated cytotoxicity in breast cancer cells with high-expressing HER2/neu , 2007, Cell Biology and Toxicology.

[52]  A. Jemal,et al.  Cancer treatment and survivorship statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[53]  D. S. St. Clair,et al.  Nucleophosmin Blocks Mitochondrial Localization of p53 and Apoptosis* , 2009, The Journal of Biological Chemistry.

[54]  F. Zheng,et al.  Inactivation of PI3-K/Akt and reduction of SP1 and p65 expression increase the effect of solamargine on suppressing EP4 expression in human lung cancer cells , 2015, Journal of Experimental & Clinical Cancer Research.

[55]  A. Zhang,et al.  Integrative Medicine for Relief of Nausea and Vomiting in the Treatment of Colorectal Cancer Using Oxaliplatin‐Based Chemotherapy: A Systematic Review and Meta‐Analysis , 2016, Phytotherapy research : PTR.

[56]  F. Zheng,et al.  Activation of AMPKα mediates additive effects of solamargine and metformin on suppressing MUC1 expression in castration-resistant prostate cancer cells , 2016, Scientific Reports.

[57]  Y. Tsujimoto,et al.  Intracellular ATP levels determine cell death fate by apoptosis or necrosis. , 1997, Cancer research.

[58]  K. Kuo,et al.  The rhamnose moiety of solamargine plays a crucial role in triggering cell death by apoptosis. , 1998, Biochemical and biophysical research communications.

[59]  J. Harbour,et al.  The Rb/E2F pathway: expanding roles and emerging paradigms. , 2000, Genes & development.

[60]  J. Yuen,et al.  Anticancer Effects of Ganoderma lucidum: A Review of Scientific Evidence , 2005, Nutrition and cancer.

[61]  F. Atanu,et al.  A review of the pharmacological aspects of Solanum nigrum Linn. , 2011 .

[62]  W. P. Norred,et al.  Pharmacology and toxicology of chaconine and tomatine. , 1975, Research communications in chemical pathology and pharmacology.

[63]  Li-Ching Chang,et al.  Solamargine upregulation of Fas, downregulation of HER2, and enhancement of cytotoxicity using epirubicin in NSCLC cells. , 2007, Molecular nutrition & food research.

[64]  F. Oesch,et al.  Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer. , 1999, Cancer research.

[65]  Ying Cheng,et al.  Correlation between HER-2/neu(erbB-2) expression level and therapeutic effect of combination treatment with HERCEPTIN and chemotherapeutic agents in gastric cancer cell lines , 2014, Cancer Cell International.

[66]  R. Zeillinger,et al.  The use of a panel of monoclonal antibodies to enrich circulating breast cancer cells facilitates their detection. , 2005, Gynecologic oncology.

[67]  B. Roufogalis,et al.  Protein and Vesicle Trafficking , Cytoskeleton Actin disruption inhibits endosomal traffic of P-glycoprotein-EGFP and resistance to daunorubicin accumulation , 2007 .

[68]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[69]  Lawrence Buja,et al.  Oncosis: an important non-apoptotic mode of cell death. , 2012, Experimental and molecular pathology.

[70]  J. Behravan,et al.  Potential role of cyclooxygenase-2 on the regulation of the drug efflux transporter ABCG2 in breast cancer cell lines , 2011, Journal of Cancer Research and Clinical Oncology.

[71]  Tak W. Mak,et al.  Cytochrome c: functions beyond respiration , 2008, Nature Reviews Molecular Cell Biology.

[72]  Fangshi Zhu,et al.  Induction of apoptosis in human hepatoma SMMC-7721 cells by solamargine from Solanum nigrum L. , 2012, Journal of ethnopharmacology.

[73]  Li-Ching Chang,et al.  Solamargine enhances HER2 expression and increases the susceptibility of human lung cancer H661 and H69 cells to trastuzumab and epirubicin. , 2008, Chemical Research in Toxicology.

[74]  Katharina D'Herde,et al.  Apoptosis and necrosis: detection, discrimination and phagocytosis. , 2008, Methods.

[75]  V. Velebný,et al.  The alpha-L-Rhamnose recognizing lectin site of human dermal fibroblasts functions as a signal transducer: modulation of Ca2+ fluxes and gene expression. , 2008, Biochimica et biophysica acta.

[76]  I. Stamenkovic,et al.  Metastatic cancer cell. , 2008, Annual review of pathology.

[77]  B. Cham,et al.  Topical treatment of malignant and premalignant skin lesions by very low concentrations of a standard mixture (BEC) of solasodine glycosides. , 1991, Cancer letters.

[78]  S. Albuquerque,et al.  In vitro Leishmanicidal and Cytotoxic Activities of the Glycoalkaloids from Solanum lycocarpum (Solanaceae) Fruits , 2013, Chemistry & biodiversity.

[79]  V. Gabai,et al.  Necrosis: a specific form of programmed cell death? , 2003, Experimental cell research.

[80]  K. Kuo,et al.  Solamargine induces apoptosis and sensitizes breast cancer cells to cisplatin. , 2007, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[81]  William C. Parks,et al.  Matrix metalloproteinases as modulators of inflammation and innate immunity , 2004, Nature Reviews Immunology.

[82]  Yuguo Du,et al.  Total Synthesis of Solamargine (I). , 2011 .

[83]  M. Cipollini,et al.  Efficacy and Mechanisms of α-Solasonine-and α-Solamargine-Induced Cytolysis on Two Strains of Trypanosoma cruzi , 2006, Journal of Chemical Ecology.

[84]  M. Friedman,et al.  Glycoalkaloids and metabolites inhibit the growth of human colon (HT29) and liver (HepG2) cancer cells. , 2004, Journal of agricultural and food chemistry.

[85]  Qing Tang,et al.  Targeting signal transducer and activator of transcription 3 contributes to the solamargine-inhibited growth and -induced apoptosis of human lung cancer cells , 2014, Tumor Biology.

[86]  Yun Yang,et al.  Purification, antitumor activity in vitro of steroidal glycoalkaloids from black nightshade (Solanum nigrum L.). , 2013, Food chemistry.

[87]  D. Green,et al.  Cytoplasmic p53: Bax and Forward , 2004, Cell cycle.

[88]  Huiqing Yuan,et al.  Solamargine, a steroidal alkaloid glycoside, induces oncosis in human K562 leukemia and squamous cell carcinoma KB cells , 2011, Cancer Chemotherapy and Pharmacology.

[89]  T. Ogawa,et al.  Isolation and Characterization of Rhamnose-binding Lectins from Eggs of Steelhead Trout (Oncorhynchus mykiss) Homologous to Low Density Lipoprotein Receptor Superfamily* , 1998, The Journal of Biological Chemistry.

[90]  J. Hamlin,et al.  Replication in the amplified dihydrofolate reductase domain in CHO cells may initiate at two distinct sites, one of which is a repetitive sequence element , 1989, Molecular and cellular biology.

[91]  P. Lala,et al.  Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions , 2014, Cancer science.

[92]  F. Kalalinia,et al.  Solamargine inhibits migration and invasion of human hepatocellular carcinoma cells through down-regulation of matrix metalloproteinases 2 and 9 expression and activity. , 2015, Toxicology in vitro : an international journal published in association with BIBRA.

[93]  Z. Werb,et al.  Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.

[94]  N. Gray,et al.  Targeting cancer with small molecule kinase inhibitors , 2009, Nature Reviews Cancer.

[95]  Qing Xu,et al.  Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy , 2015, Autophagy.

[96]  H. Lou,et al.  Induction of actin disruption and downregulation of P-glycoprotein expression by solamargine in multidrug-resistant K562/A02 cells. , 2011, Chinese medical journal.

[97]  K. Fraser,et al.  E/Z-Thesinine-O-4'-alpha-rhamnoside, pyrrolizidine conjugates produced by grasses (Poaceae). , 2008, Phytochemistry.

[98]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[99]  B. Coomber,et al.  Solamargine triggers cellular necrosis selectively in different types of human melanoma cancer cells through extrinsic lysosomal mitochondrial death pathway , 2016, Cancer Cell International.

[100]  M. Rovers,et al.  SYRCLE’s risk of bias tool for animal studies , 2014, BMC Medical Research Methodology.

[101]  Li-Ching Chang,et al.  Solamargine induces apoptosis and enhances susceptibility to trastuzumab and epirubicin in breast cancer cells with low or high expression levels of HER2/neu. , 2009, Bioscience reports.

[102]  Yifa Zhou,et al.  In vivo antimalarial activities of glycoalkaloids isolated from Solanaceae plants , 2010, Pharmaceutical biology.